The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.Starting at 9 a.m. ET on December 10th, vaccine experts will review the data supporting Pfizer and BioNTech’s Covid-19 vaccine, all of which is a prelude to the FDA’s decision to grant it an emergency use authorization.
LIVE STREAM: FDA VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE MEETING
